ইব্রুসেন্ট ক্যাপসুল এর উপকারিতা কি?

Ibrutinib, is a kinase inhibitor indicated for the treatment of patients with: 

• Mantle cell lymphoma (MCL) who have received at least one prior therapy. Accelerated approval was granted for this indication based on overall response rate. Continued approval for this indication may be contingent upon verification of clinical benefit in confirmatory trials.
• Chronic lymphocytic leukemia (CLL) who have received at least one prior therapy
• Chronic lymphocytic leukemia with 17p deletion
• Waldenström's macroglobulinemia (WM)

Ibrucent Capsule সম্পর্কে বিস্তারিত জেনে নিন এই লিঙ্ক থেকে Ibrucent